Pharmaceutical Biotechnology Questions and Answers – Physical and Chemical Instability

This set of Pharmaceutical Biotechnology Multiple Choice Questions & Answers (MCQs) focuses on “Physical and Chemical Instability”. 1. Which of the following causes physical instability in parenteral solution? a) pH b) Changes in chemical composition c) Viscosity d) Temperature 2. What is the name of the property that describes the process of absorption of moisture … Read more

advertisement

Pharmaceutical Biotechnology Questions and Answers – Biopharmaceuticals – Peptide and Protein Structure Stability Profile – 2

This set of Pharmaceutical Biotechnology Questions and Answers for Freshers focuses on “Biopharmaceuticals – Peptide and Protein Structure Stability Profile – 2”. 1. What is the name of the bond which is caused by changes in electron density? a) Vander Waals force b) H bond c) Hydrophobic interaction d) Electrostatic bond 2. Which of the … Read more

advertisement

Pharmaceutical Biotechnology Questions and Answers – Biopharmaceuticals – Peptide and Protein Structure Stability Profile – 1

This set of Pharmaceutical Biotechnology Interview Questions and Answers focuses on “Biopharmaceuticals – Peptide and Protein Structure Stability Profile – 1”. 1. Interactions between atoms within the protein chain are one of the main forces that stabilize covalent structures in Proteins. a) True b) False 2. One of the Main Forces that stabilize covalent structures … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Transdermal Drug Delivery Systems

This set of Drug Biotechnology Multiple Choice Questions & Answers (MCQs) focuses on “Biopharmaceuticals – Transdermal Drug Delivery Systems”. 1. Which of the following drugs cannot be given as transdermal administration? a) Drugs with very short half-lives b) Drugs with narrow therapeutic indices c) Easy removal and termination d) Drugs against peptic ulcer 2. Which … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Parenteral Controlled Release Systems – 2

This set of Drug Biotechnology Assessment Questions and Answers focuses on “Biopharmaceuticals – Parenteral Controlled Release Systems – 2”. 1. Which of the following should not be a property of implants? a) Environmental stable b) Biostable c) Non-toxic d) Nonremovable 2. Which is the disadvantage for implants? a) More effective b) More prolonged action c) … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Parenteral Controlled Release Systems – 1

This set of Pharmaceutical Biotechnology Multiple Choice Questions & Answers (MCQs) focuses on “Biopharmaceuticals – Parenteral Controlled Release Systems – 1”. 1. The duration of action of parental controlled release systems can be extended up to what time? a) 1 day b) 1 week c) 1 month d) Day, week, month even a year 2. … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Oral Controlled Release Systems – 2

This set of Drug Biotechnology Questions and Answers for Campus interviews focuses on “Biopharmaceuticals – Oral Controlled Release Systems – 2”. 1. Which of the following oral controlled release system is shown in the picture? a) Matrix system b) Encapsulated system c) Rigid matrix d) Swellable matrix 2. Which of the following oral controlled release … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Oral Controlled Release Systems – 1

This set of Drug Biotechnology Multiple Choice Questions & Answers (MCQs) focuses on “Biopharmaceuticals – Oral Controlled Release Systems – 1”. 1. Oral controlled release drugs release the drug only inside the intestine. a) True b) False 2. What are the characteristics of continuous release systems? a) Release the drug along the entire length of … Read more

advertisement

Drug Biotechnology Questions and Answers – Biopharmaceuticals – Pharmacotherapy of Multiple Sclerosis

This set of Drug Biotechnology online test focuses on “Biopharmaceuticals – Pharmacotherapy of Multiple Sclerosis”. 1. Which age group is more prone to Multiple sclerosis? a) 0-5 years b) 20-75 years c) Adults of above 20 years d) Adults of above 70 years 2. Chances in females are more than in men. a) True b) … Read more

advertisement

Drug Biotechnology Questions and Answers – Controlled Release Medication – Pharmacotherapy of Diabetes – 2

This set of Drug Biotechnology Questions and Answers for Entrance exams focuses on “Controlled Release Medication – Pharmacotherapy of Diabetes – 2”. 1. Which of the following is a drug for diabetes mellitus? a) Omeprazole b) Acetanilide c) Biguanides d) Amlodipine 2. Which of the following is a drug for diabetes mellitus? a) Alpha-glucoside inhibitors … Read more

advertisement
Subscribe to our Newsletters (Subject-wise). Participate in the Sanfoundry Certification contest to get free Certificate of Merit. Join our social networks below and stay updated with latest contests, videos, internships and jobs!

Youtube | Telegram | LinkedIn | Instagram | Facebook | Twitter | Pinterest
Manish Bhojasia - Founder & CTO at Sanfoundry
Manish Bhojasia, a technology veteran with 20+ years @ Cisco & Wipro, is Founder and CTO at Sanfoundry. He lives in Bangalore, and focuses on development of Linux Kernel, SAN Technologies, Advanced C, Data Structures & Alogrithms. Stay connected with him at LinkedIn.

Subscribe to his free Masterclasses at Youtube & discussions at Telegram SanfoundryClasses.